RON LENNOX

Ron has invested broadly in the life science sector with an emphasis on biotechnology and molecular diagnostics. He has served on the boards of eighteen companies, was founding CEO of two Yale start-ups, Protometrix, Inc. and CGI Pharmaceuticals, Inc (acquired by Gilead Sciences, Inc.) and worked in, with and invested in many more life science companies.